Finance

Lists
KLRS:NASDAQ
Kalaris Therapeutics Inc
$ 3.73
-4.85%
(-0.19) 1D
7-р сарын 24, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRS...
Open
$ 3.87
High
$ 3.96
Low
$ 3.52
Mkt. cap
88.75 сая
Avg. vol.
458.60 мян
Volume
157.76 мян
52-wk high
$ 11.88
52-wk low
$ 2.14
EPS
-$ 2.21
Beta
0.19
Shares outstanding
23.79 сая
No. of employees
20
Open
$ 3.87
High
$ 3.96
Low
$ 3.52
Mkt. cap
88.75 сая
Avg. vol.
458.60 мян
Volume
157.76 мян
52-wk high
$ 11.88
52-wk low
$ 2.14
EPS
-$ 2.21
Beta
0.19
Shares outstanding
23.79 сая
No. of employees
20
News stories
From sources across the web
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, Нью Жерси, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to KLRS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KLRS in the last 3 months.
Highest
Current $ 3.73
$ 25.00 (+570.24%)
Average
$ 18.67 (+400.54%)
Lowest
$ 14.00 (+275.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
07/17/2026
Yun Zhong
Wedbush
Buy
Maintained
$ 17.00
+355.8%
07/17/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$ 14.00
+275.3%
07/17/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
06/15/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$ 25.00
+570.2%
05/13/2026
Biren Amin
Piper Sandler
Hold
Maintained
$ 7.00
+87.7%
03/30/2026
Daniil Gataulin
Chardan Capital
Buy
Initiated
$ 19.00
+409.4%
12/23/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 6-р сар
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.44 сая
9.13 сая
7.16 сая
7.57 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.82 сая
3.62 сая
3.64 сая
4.26 сая
Operating expense
12.26 сая
12.74 сая
10.80 сая
11.83 сая
Total operating expenses
12.26 сая
12.74 сая
10.80 сая
11.83 сая
Operating income
-12.26 сая
-12.74 сая
-10.80 сая
-11.83 сая
Other non operating income
906.00 мян
847.00 мян
803.00 мян
977.00 мян
EBT including unusual items
-11.35 сая
-11.89 сая
-10.00 сая
-10.86 сая
EBT excluding unusual items
-11.35 сая
-11.89 сая
-10.00 сая
-10.86 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.35 сая
-11.89 сая
-10.00 сая
-10.86 сая
Net profit margin
-
-
-
-
Earnings per share
-0.61
-0.64
-0.44
-0.46
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-12.74 сая
-10.79 сая
-11.82 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more